Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib
Clinical trial NCT01298063 · COMPLETED
Trial details
- NCT number
- NCT01298063
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.